In colorectal cancer, the p52-ZER6 isoform positively influences the interaction of p53 with MDM2, which leads to the ubiquitination of p53, and lowered expression of its target genes participating in cell cycle restriction. The gene discussed is TP53; the disease is colorectal cancer.